Late Breaking Abstract - Effects of long-term Tobramycin Inhalation Solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. The BATTLE Randomized Controlled Trial

L. Terpstra (Alkmaar (NH), Netherlands), I. Bronsveld (Utrecht, Netherlands), J. Doodeman (Alkmaar (NH), Netherlands), W. Rozenmeijer (Alkmaar (NH), Netherlands), H. Heijerman (Utrecht, Netherlands), W. Boersma (Alkmaar (NH), Netherlands)

Source: Virtual Congress 2020 – ALERT: Infection in adults and children
Session: ALERT: Infection in adults and children
Session type: Clinical trials session
Number: 4134

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Terpstra (Alkmaar (NH), Netherlands), I. Bronsveld (Utrecht, Netherlands), J. Doodeman (Alkmaar (NH), Netherlands), W. Rozenmeijer (Alkmaar (NH), Netherlands), H. Heijerman (Utrecht, Netherlands), W. Boersma (Alkmaar (NH), Netherlands). Late Breaking Abstract - Effects of long-term Tobramycin Inhalation Solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. The BATTLE Randomized Controlled Trial. 4134

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: